Did you make the cut? MM&M Awards finalists announced

Share this article:
Did you make the cut? MM&M Awards finalists announced
Did you make the cut? MM&M Awards finalists announced

Following two comprehensive rounds of scoring by more than 100 independent industry judges, the results are in for the MM&M Awards 2013. To see the five finalists for each of the 23 categories, CLICK HERE—but you'll have to wait for the spectacular dinner and ceremony at Cipriani 42nd Street in New York on October 2, 2013 to find out who will take home the gold and silver awards.

The MM&M Awards are judged with the utmost independence and authority, using an esteemed panel of leaders and thinkers representing a wide variety of disciplines and backgrounds within the healthcare marketing community.

But even the judges won't know the identities of the gold and silver winners until they are revealed for the first time on October 2.

CLICK HERE for the complete list of finalists.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...